...
机译:在腹咽157 HPV阳性和HPV阴性鳞状细胞癌中鉴定预后分子生物标志物
Department of PathologyMemorial Sloan Kettering Cancer CenterNew York NY;
Department of PathologyMemorial Sloan Kettering Cancer CenterNew York NY;
Department of PathologyMemorial Sloan Kettering Cancer CenterNew York NY;
Department of PathologyMemorial Sloan Kettering Cancer CenterNew York NY;
Department of PathologyMemorial Sloan Kettering Cancer CenterNew York NY;
Department of SurgeryMemorial Sloan Kettering Cancer CenterNew York NY;
Department of SurgeryMemorial Sloan Kettering Cancer CenterNew York NY;
Department of Epidemiology and BiostatisticsMemorial Sloan Kettering Cancer CenterNew York NY;
Department of SurgeryMemorial Sloan Kettering Cancer CenterNew York NY;
HPV; oropharynx; squamous cell carcinoma; NOTCH1; SOX2;
机译:在腹咽157 HPV阳性和HPV阴性鳞状细胞癌中鉴定预后分子生物标志物
机译:HPV阳性和HPV阴性口咽鳞状细胞癌甲基化谱的差异系统评价
机译:与HPV阳性头部和颈鳞状细胞癌相关的免疫相关预后生物标志物的鉴定
机译:口腔鳞状细胞癌的HPV流行和oropharynx作为生物行为标记
机译:MicroRNA-137启动子甲基化作为头颈部鳞状细胞癌的病因和预后生物标志物。
机译:HPV阳性和HPV阴性口咽鳞状细胞癌甲基化谱的差异
机译:对于HpV阳性和HpV阴性局部晚期鳞状细胞癌患者,每周化疗放疗与高剂量顺铂联合放射治疗器官